Execs On The Move: Changes In Finance Talent At Globus, Senzime And Zimmer; New Medical Chiefs At BioPorto And DBV
New chief financial officers for Globus Medical, Senzime and Zimmer Biomet. Plus in vitro diagnostics company BioPorto and food allergy firm DBV Technologies appoint chief medical officers.
You may also be interested in...
The Chinese government's plan to reduce tariffs it imposed on a slew of US exports is expected to have minimal impact on the overall medtech industry. See what Ralph Ives, AdvaMed's executive VP for global strategy, said about it here.
FDA approved sNDAs from GlaxoSmithKline for diclofenac-containing Voltaren Arthritis Pain for the temporary relief of arthritis pain and from Alcon for Pataday olopatadine drops at 0.2% concentration for once-daily use temporary relief of itchy eyes due to pollen, ragweed, grass, animal hair or dander and 0.1% for twice-daily use for the same indications plus redness relief.